News

Certara Welcomes Jon Resnick as New CEO for Future Growth

Certara Welcomes Jon Resnick as New CEO for Future Growth

Certara Appoints Jon Resnick as Chief Executive Officer

In a significant leadership transition, Certara, Inc. has announced the appointment of Jon Resnick as its new Chief Executive Officer, effective January 1, 2026. Resnick's impressive background in health sciences and business operations positions him uniquely to lead the company into its next growth phase.

Lead Through Experience

Resnick comes to Certara with over 20 years of accumulated experience at IQVIA, a vital player in the life sciences sector that leverages data and analytics to accelerate the development of therapies. He has most recently held the role of President for the U.S. and Canada regions, where he honed his skills in managing commercial operations.

Before his presidency, Resnick contributed significantly to IQVIA’s Real World Solutions business during its critical merger between IMS Health and Quintiles. His previous stints at IMS Health involved roles that directly influenced the company’s US and EMEA consulting strategies and services.

Vision for Future Innovation

James E. Cashman III, Chairman of the Board of Directors, expressed optimism about Resnick’s leadership. "We are excited to welcome Jon to Certara. His proven track record of innovation in healthcare, as well as his ability to build strong collaborative teams, will be invaluable as we look to leverage model-informed drug development to enhance patient care," Cashman stated.

Commitment to Client Success

Resnick shares this excitement, emphasizing his dedication to Certara's mission. “Joining Certara represents a unique opportunity to be part of a company that is globally recognized for its advancements in drug discovery and development. The capabilities we possess in AI and biosimulation technology put us in a prime position to help clients navigate their challenges effectively,” said Resnick.

Leadership Transition and Legacy

As Resnick steps into his role, William F. Feehery will transition to an advisory position, offering his insights for a smooth transition. Feehery's tenure has been marked by successful milestones, including Certara’s IPO and enhanced investments in software development.

"I am incredibly proud of what we have accomplished at Certara. We have made strides in biosimulation adoption and have empowered our clients to advance their medicines more swiftly and confidently,” said Feehery, highlighting a strong sense of commitment to the company’s future.

Certara’s Upcoming Ventures

In conjunction with this transition, Certara has reaffirmed its financial outlook for 2025, echoing prior announcements made earlier. The company anticipates a robust future, built on the foundation laid by previous leadership while leveraging new strategies introduced by Resnick.

About Certara

Certara stands at the forefront of drug development, utilizing proprietary biosimulation software and data-driven technologies to enhance and transform the traditional processes of drug discovery. With a clientele that spans over 2,400 biopharmaceutical organizations and regulatory bodies across 70 nations, Certara's impact is truly global.

Looking Ahead with Certara

As the life sciences industry continues to evolve, Certara remains committed to empowering its partners with the tools and insights essential for navigating the complex landscape of drug development. With Jon Resnick at the helm, the path forward looks promising and full of possibility.

Frequently Asked Questions

Who is Jon Resnick?

Jon Resnick is the newly appointed CEO of Certara, bringing over 20 years of experience in the life sciences industry.

What did Resnick do before joining Certara?

Prior to Certara, Resnick served as President of IQVIA's U.S. and Canada operations, focusing on business strategy and commercial growth.

What is Certara's mission?

Certara aims to improve drug discovery through innovative biosimulation technologies and software, enhancing the overall development process for pharmaceuticals.

Who will Jon Resnick succeed at Certara?

Jon Resnick will succeed William F. Feehery, who served as CEO and will assist during the transition period.

How does Certara support its clients?

Certara utilizes its expertise to provide biopharmaceutical companies with the necessary tools to minimize risks and accelerate drug development timelines.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 208

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 6

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 17

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 96

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
Utility Global’s India Steel Move Needs Hard Numbers

Updated Category News Views 104

Steel decarbonization announcements can sound enormous before a single bolt gets tightened. Utility Global says it plans to deploy its first industrial H2Gen project in India with Tata Steel, and that is plainly worth watching. Tata Steel is a serious industrial name, India is a consequential steel market, and any technology that can credibly lower emissions from heavy...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
LONGi's Solar-Storage Push Faces Africa's Cost Wall

Updated Category News Views 22

A vaccine refrigerator humming through a blackout is more meaningful than another climate-conference slogan. That was the useful thread running through LONGi's November 13 COP31 side event in Antalya, Türkiye: solar and storage are not merely hardware for remote communities. When designed, financed and maintained properly, they can keep clinics, water pumps and other...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 156

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 67

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading

Top 5 Most Recently Viewed Articles

Natus Medical Unveils Advanced EMG Software for Enhanced Use

Updated Category News Views 116

Natus Medical's Latest EMG Software Release Natus Medical Incorporated is excited to announce the launch of its newest edition of the Natus Elite EMG software. This software continues to set a high standard in the neurodiagnostic field, delivering both familiarity and reliability that users have come to expect. What makes this release particularly noteworthy is the...

Continue Reading
Toll Brothers Unveils New Luxury Homes in August Park Community

Updated Category News Views 231

Your Dream Home Awaits at August Park Toll Brothers, Inc., a leader in luxury home building, recently announced the launch of an exciting new community known as Toll Brothers at August Park. This neighborhood promises not just high-end living but also a tranquil environment perfect for families and individuals seeking a peaceful lifestyle. Located in a serene area, this...

Continue Reading
Johnny Bigg Expands Presence with New Concessions in Retail

Updated Category News Views 678

Johnny Bigg's Exciting Expansion into Retail Johnny Bigg, a popular fashion brand dedicated to big and tall men, continues to grow its presence in the retail landscape. Recently, the company took a significant step by launching concessions in selected Belk stores. This move marks an important milestone for Johnny Bigg, showcasing its commitment to making fashionable...

Continue Reading
Exploring Sound Investments With Warren Buffett's Wisdom

Updated Category News Views 284

Warren Buffett stood tall as the legendary investor who transformed Berkshire Hathaway into a $1 trillion powerhouse. Back then, this valuation didn’t hinge on flashy products or industry domination. It was all about Buffett’s knack for hunting down stocks that consistently outperformed the market. Berkshire Hathaway's Focused Portfolio: Goldmine or Gimmick? At one...

Continue Reading
Understanding KPIs: A Key to Effective Life Science Marketing

Updated Category News Views 205

Understanding the Importance of KPIs in Life Science Marketing In today's fast-paced life science sector, it's crucial for organizations to utilize data-driven decisions to enhance customer engagement. However, surprisingly, thirty-two percent of marketing and analytics teams in the life sciences report either not knowing about or not using key performance indicators...

Continue Reading